Tesamorelin 10mg Peptides
Designed for disciplined research, this vial delivers reliable consistency from the first measurement to the last.
Well Elevation Tesamorelin is a 10mg lyophilized research peptide vial formulated for precise laboratory work. Presented as a freeze-dried powder (no flavor), this growth hormone-releasing hormone analog is provided in a controlled, lab-ready format with a total content of 10mg per vial. The presentation supports careful measurement, clean handling, and methodical study protocols across qualified research settings.
- Each vial contains 10mg of Tesamorelin, a growth hormone-releasing hormone analog studied for selective engagement with GHRH pathways, controlled assessment of GH axis activity, and related metabolic research endpoints in validated laboratory models.
As a non-edible, lab-use format, the lyophilized powder is engineered for accurate reconstitution by qualified personnel using appropriate sterile techniques and materials. Researchers value the format for its measured dosing control and compatibility with standard laboratory workflows. The clean presentation is intended to minimize variability introduced by handling, aiding reproducibility and consistency when protocols demand tight tolerances and traceable inputs.
Every vial is sourced and handled in the United States under rigorous quality expectations. Lots are tested for identity and purity with documentation available, supporting transparent verification before use. Each batch is lot-tracked to maintain chain-of-custody clarity from receipt through study execution. Packaging and fulfillment prioritize product integrity, with careful environmental controls and secure sealing to protect the lyophilized matrix during shipment.
Well Elevation operates with a standards-first mindset: clear labeling, precise content specifications, and research-use-only positioning. This product is intended strictly for laboratory research by qualified professionals. It is not a drug, food, or cosmetic; not for human or animal use; not for diagnostic or therapeutic applications. Follow institutional safety procedures, employ aseptic technique where applicable, and consult your laboratory’s reconstitution and storage protocols to align with study requirements. Certificates of Analysis and lot details are available to support documentation, review, and audit needs.
Choose Well Elevation for a modern, USA-based research partner committed to purity, consistency, and transparency—so your work can proceed with confidence in the compound behind the data.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is Tesamorelin?
Tesamorelin is a synthetic analog of growth hormone-releasing hormone. It belongs to the same broad family as other GHRH-based peptides, but it is typically discussed as a distinct compound with its own pharmacologic profile. For a research-products site, it should be described as a laboratory peptide for GH-axis and metabolic-endocrine studies.
What is Tesamorelin typically studied for?
Tesamorelin is commonly studied for endogenous growth-hormone release, IGF-1 signaling, and body-composition or visceral-fat-related endocrine models. The best FAQ wording stays close to those research themes and avoids translating them into simplistic consumer promises.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Well Elevation are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
